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properties and can provide new and improved ways to diagnose and treat diseases.
[1] The performance of nanostructured polymer particles in a biological setting is governed by their ability to interact with and address biological barriers.
[2] Important factors determining this behavior include chemical and physical parameters, such as surface chemistry, size, shape, and elasticity.
[3]
Different strategies have been investigated to avoid degradation and excretion of nanostructured particles. One prominent technique is the coating of particles with "stealth" materials such as poly(ethylene glycol) (PEG) or "self" peptides. [4] A high density stealth coating could improve penetration of large polymer particles and prolong their circulation time. [5] However, an incomplete or insufficient coating can limit the efficacy of such approaches. [6] A current challenge is accurately quantifying the surface coverage of stealth coatings on polymer particles. [7] One possible way to address this challenge is to assemble particles solely made of materials such as PEG. Another important aspect of particle design is softness and deformability. Many mammalian cells have the remarkable capacity of reversible deformation. For example, human red blood cells (RBCs) have a mean diameter of ~7.5 µm and routinely traverse tissue blood capillaries with diameters that can be smaller than 5 µm. [8] Aged RBCs become rigid and lose this ability, which is reported to induce their clearance from the blood by splenic filtration. [9] Therefore, this flexibility is one of the key properties that enables long circulation of RBCs, and the reduced deformability is a characteristic of several pathological states. [10] It has been reported that the stiffness of nanoparticles plays an important role in their in vivo behavior: softer particles typically have longer circulation times and lower splenic accumulation. [11] Microfluidic devices have been recently used to mimic in vivo environments for studying the biological behavior of engineered particles. [12] Particles made of nanostructured materials that combine stealth properties with tunable mechanical properties are therefore of great interest for biological applications.
In the last few years, there have been several important steps made toward engineering soft particles with stealth properties. Using mixtures of diacrylated PEG with a photoinitiator and other acrylated polymers or PEG, templated or mask-based photopolymerization have been used to prepare hydrogel particles with tunable elasticity.
[13] Such properties were achieved by varying the amount of diacrylated PEG used in prepolymer mixtures, as determined through electromechanical measurements on the bulk material and/or deformability behavior of particles inside designed microfluidic networks. Another route that has been explored is the use of layer-by-layer assembly to engineer particles that mimic RBCs. [14] Although these studies represent important advances, the particles were made of several components, including non-stealth components. In addition, the elasticity of the particles related to their behavior in microfluidic microchannels were only measured on the bulk material, rather than the particles. Furthermore, direct comparisons to the deformability behavior of RBCs in microfluidic channels were not reported.
Previously, we reported a robust approach for preparing polymer replica particles using a mesoporous silica (MS) templating method, where the template is removed following polymer infiltration and cross-linking. [15] This versatile method has been used to prepare particles of different size, shape, chemical composition, and elasticity, which have the capacity for both cargo encapsulation and delivery. [16] However, previous studies have not reported the preparation of stealth polymer replica particles with tunable elasticity.
Herein, we engineer PEG hydrogel particles with tunable elasticity and with a similar size to human RBCs via a MS templating method, followed by investigation of particle deformability using atomic force microscopy (AFM) and a microfluidic blood capillary model In addition to the material type, the elasticity is also dependent on the material density. As the relative amount and/or density of PEG in each particle changed according to the amount of cross-linker used, we expected that the elasticity of the PEG particles would also vary with the cross-linker concentration. To measure the elasticity of the PEG particles, CP-AFM experiments were carried out.
[17] High-resolution force maps were performed on single PEG particles with different cross-linking densities. CP-AFM measurements were performed on individual PEG particles dispersed in 20 mM phosphate buffer on a glass slide. An array of force curves were then collected over a 25 × 25 µm area, and then modified to give forcedeformation information. Due to adhesive contact between the colloidal probe and particle, as well as possible viscoelastic effects and associated hysteresis, only the approach force curve was analyzed (Figure 2a) . It was found that the Young's modulus (E Y ) of the PEG particles could be finely tuned by adjusting the cross-linker concentration (Figure 2b ), which is consistent with our previous findings that the E Y of poly(methacrylic acid) and poly(Lglutamic acid) particles increases with increasing the cross-linker concentration.
[16c, 18] However, the obtained PEG particles were super-soft with a tunable E Y from 0.2 to 3.3 kPa (stiffness range from 0.3 to 3 mN m -1 ), which is extremely low compared with previously reported polyelectrolyte particles (2-23 kPa), protein particles (~4 kPa) or PEG-based particles (7.8-64 kPa). [13b,16c,19] We hypothesize this is due to the low material density within the cross-linked structure.
E Y values determined using JPK data processing software were arranged into a matrix and then graphically represented in three dimensions ( Figure S2a-d) . Based on the repetitive nature of the force mapping with little variability in elucidated modulus and height, it is seen that the PEG particles deformed elastically. From the force maps, E Y values for the substrate have been removed for clarity, and it can be seen that there is a homogeneous region in the center of the particles, with decreasing modulus toward the edges due to edge effects during compression. Additionally, the diameter of the PEG particles is much larger than that of the dispersed particles (7-9 µm), which can be explained by the radius of curvature (12.5 µm) for the spherical probe used (Figure S2e-h ). Human RBCs with a E Y of ~26 kPa can easily pass through capillaries with dimensions smaller than their size and have a long circulation time in vivo (about 120 days). [11, 20] were obtained (Figure 3a) . Here, pressure drops (2-20 mbar) were established over the microchannels, which are comparable to the in vivo pressure drops across typical human blood capillaries (~1-10 mbar). [21] The parameters for the simulations of flow in the microfluidic device are listed in Table S1 . The refined and validated design was then realized using soft lithography ( Figure 3b ) and consisted of a high-pressure and a low-pressure side To test the deformability behavior of PEG particles in capillaries, the inlet pressures were chosen based on the simulations to achieve physiologically relevant pressure drops across the microchannels. The PEG particles were injected from the high pressure inlet and only buffer was used in the second inlet. The highly cross-linked PEG particles had trouble passing through the microchannels, especially at lower pressure differentials (Figure 4a) . In contrast, lowly cross-linked PEG particles could more easily deform to fit inside the microchannels and pass through (Figure 4b) . Interestingly, no damage to the spherical shape was observed when comparing PEG particles before and after passing through the microchannels. This indicates that PEG particles can pass through microchannels that are smaller than the particle diameter through reversible elastic deformation. As a comparison, human RBCs were also tested in the microfluidic blood capillary model. They could also pass through the microchannels and recover their shape, as expected (Figure 4c ). [8, 22] Number of particles that passed through the capillaries was divided by the number that went to the outlet on the same side. Mean ± standard deviation, n = 3.
To quantify the deformability of the PEG particles with different cross-linking densities in microchannels, a ratio of the number of particles that passed through the microchannels to the number of particles that did not was calculated. Particles that can easily pass through will have a high ratio while particles that do not pass through at all will have a ratio of zero. Each measurement was performed in triplicate with more than 100 particle trajectories analyzed for each replicate. In total over 20,000 particle trajectories were analyzed. The results demonstrate a clear inverse correlation between amount of cross-linker used and the ease with which particles can pass through the microchannels (Figure 4d ). This correlates well with the AFM data (Figure 2) , where a decrease in cross-linker used resulted in a decrease in E Y, corresponding to an increase in softness, which here translates to an increased capacity to deform to pass through the microchannels. Further, the PEG particles pass through the microchannels more easily when the pressure drops increased, as expected. Virtually none of the control PEG particles with the hard MS template still remaining (MS@PEG) could pass through the microchannels, even at the highest pressure differential used, as expected.
Interestingly, when the linker concentration decreased to 0.5 mg mL -1 , the lowly cross-linked PEG particles with an E Y of 0.2 kPa behaved similar to RBCs in the microfluidic blood capillary model. It should be noted that even though the E Y of highly cross-linked PEG particles is still lower than that of RBCs, they do not pass through the capillary model as well as RBCs. This is due to a combination of geometric differences between biconcave-discoidal RBCs and spherical PEG particles with distinct internal volumes, along with effects from the RBC cytoplasmic viscosity and contrasts in mechanical deformation of the respective membranes. [20, 23] Nevertheless, the obtained PEG particles demonstrate tunable elasticity and they can be made to behave similar to RBCs under physiologically relevant conditions in a microfluidic blood capillary model, thus making them potentially useful for biomedical applications, such as targeted drug delivery.
In summary, super-soft hydrogel particles made of 8-arm-PEG were successfully fabricated via a MS templating method. These PEG particles were well dispersed in aqueous Characterization Methods: Images were acquired using transmission electron microscopy (Philips CM120 BioTWIN), atomic force microscopy (NanoWizard II AFM) and fluorescence microscopy (Olympus IX71). Fluorescence intensity of PEG particles were measured on an Apogee Micro Flow Cytometer. Mechanical characterization of the PEG particles was performed using a Nanowizard II AFM equipped with a fluorescence microscope (Leica DMI4000B). [24] The microfluidic model mimicking aspects of human blood capillaries was made through soft lithography. [25] Full experimental details are available in the Supporting Information.
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